alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2
 CERTIFICATION
  1.
 2.
 3.
 4.
 a)
    
    Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;b)
    
    Designed such internal control over financial reporting, or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally accepted
accounting principles;c)
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such
evaluation; andd)
    
    Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and
 5.
 a)
    
    All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
andb)
    
    Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
 Dated: August 5, 2008
    /s/ Gregory W. SchaferGregory W. SchaferVice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan



### October 27, 2008 Clifford W. Taylor, Chief Justice



### 137041 Michael F. Cavanag h Elizabeth A. Weave r Marilyn Kell y Maura D. Corriga n 

### PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, J ustices



### v SC: 137041 COA: 274236 Berrien CC: 05-406865-FC DOMACO SIMS, 05-406866-FC Defendant-Appellant.

________________ _________________________/

On order of the Court, the application for leave to appeal the July 17, 2008 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

1020 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

October 27, 2008

Clerk
Record of Ex Parte Contacts

Docket No. FAA - 2011 - 1415 Directorate Identifier: 2011 - NM - 145 - AD **With whom outside the FAA has this AD action been discussed (i.e., Design Approval Holder, manufacturer, ATA, NBAA, RAA, AOPA, ALPA, GAMA, etc)?**  (You might need to submit a separate record to the Rules Docket. The AD Manual defines “ **Ex Parte Contacts** .”) ORGANIZATION PERSON CO NTACTED DATE RESPONSE ATA Mike Bianchi 6/17/2011 Concur. (202) 626 - 4228

Other/Additional Information:
Slip Op. 06-81 UNITED STA TES COU RT OF INTER NATIONA L TRADE

____________________________________ : FORMER EMPL OYEES O F : QUALITY F ABRICAT ING, INC., : : Pl ain tif fs , :

: : Before: W ALLACH , Judge v. : Court No.: 02-00522 : UNITED STA TES : SECRETA RY OF LA BOR, : : De fe nd an t. : ____________________________________:
ORDER Pursuant to t he Opinion of the Court of Appeals for the Feder al Circuit dated May 24, 2006, it is her eby OR DE RE D, AD JU DG ED , and DE CREE D tha t th is m att er b e, an d h ere byis DISMISSED for lack of jurisdict ion.

____/s/ Evan J. Wallach____ Evan J. Wallach, Judge
Dated: May 26, 2006

Ne w Y ork , N ewYo rk
**Exhibit 24****POWER OF ATTORNEY**Each director and/or officer of Retail Ventures, Inc. (the “Corporation”) whose signature appearsbelow hereby appoints Heywood Wilansky, James A. McGrady and Julia A. Davis as the undersigned’sattorney or any of them individually as the undersigned’s attorney, to sign, in the undersigned’sname and behalf and in any and all capacities stated below, and to cause to be filed with theSecurities and Exchange Commission (the “Commission”), the Corporation’s Annual Report on Form 10-K(the “Form 10-K”) for the fiscal year ended February 2, 2008, and likewise to sign and file withthe Commission any and all amendments to the Form 10-K, and the Corporation hereby appoints suchpersons as its attorneys-in-fact and each of them as its attorney-in-fact with like authority tosign and file the Form 10-K and any amendments thereto granting to each attorney-in-fact full powerof substitution and revocation, and hereby ratifying all that any such attorney-in-fact or theundersigned’s substitute may do by virtue hereof.IN WITNESS WHEREOF, wehave hereunto set our hands effective as of the 24 day of April, 2008.   /s/ Jay L. Schottenstein Jay L. Schottenstein Chairman of the Board of Directors    /s/ Heywood Wilansky President and Chief Executive Officer and Heywood Wilansky Director (Principal Executive Officer)   /s/ James A. McGrady James A. McGrady Executive Vice President, Chief Financial Officer, Treasurer and Secretary
Consent(Director)


EXHIBIT 10-03

SHOTGUN ENERGY CORPORATION

(the “Company”)

CONSENT TO ACT AS OFFICER

I hereby consent to act as a President and Chief Executive Officer of the Company and acknowledge that I am not disqualified to become or to act as a director under Chapter 78 of the Nevada Revised Statutes.

I hereby confirm that:

1

I am not under the age of 18 years;

2

I have not been found by a court, in the United States of America or elsewhere, to be incapable of managing my own affairs;

3

I am not an undischarged bankrupt; and

4

I have not been convicted in or out of Nevada of an offence in connection with the promotion, formation or management of a corporation or unincorporated business, or of an offence involving fraud.




In addition, the undersigned hereby consents to the holding of any meeting of the directors or of a committee of the directors of the Company by means of such telephonic, electronic or other communication facility, as permit all persons participating in the subject meetings to communicate adequately with each other.




This consent shall continue in effect from year to year so long as the undersigned is re-elected to the board of directors, provided that in the event that the undersigned revokes this consent or resigns from the board of directors, this consent shall cease to have effect from the date of receipt in writing by the Company of such revocation or resignation, as the case may be, or, if the latter, the effective date of such resignation.

DIRECTORS HAVE SUBSTANTIAL DUTIES AND OBLIGATIONS AND MAY BE SUBJECT TO SIGNIFICANT LIABILITIES. THE PERSON SIGNING THIS CONSENT SHOULD OBTAIN INDEPENDENT LEGAL ADVICE.

		
	Dated

	November 18, 2008


	Print name

	Christopher Scheive


	Address

	


400 Blvd. Thomas

Unit 400

Lachute, Quebec, J8H 1V7


	Signature

	/s/: C. Scheive
<PAGE>


                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Moore Medical Corp. (the "Company") on
Form 10-K for the fiscal year ended December 28, 2002 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, John M.
Zinzarella, Vice President of Finance, Treasurer and Chief Financial Officer of
the Company, certify, pursuant to Section 18 U.S.C. 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) and 15(d)
of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

  /s/ John M. Zinzarella
--------------------------------
John M. Zinzarella, CPA
Vice President of Finance,
Treasurer and Chief Financial Officer
March 28, 2003
Exhibit 32.2  CERTIFICATION
PURSUANT TO 
18 U.S.C. SECTION 1350, 
AS ADOPTED PURSUANT TO 
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Annual
Report of Cephalon, Inc. (the Company) on Form 10-K for the year
ended December 31, 2009 as filed with the Securities and Exchange
Commission on the date hereof (the Report), I, Wilco Groenhuysen, Executive
Vice President and Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of
2002, based on my knowledge, that:  (1)           The Report fully complies with the
requirements of section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and  (2)           The information contained in the
Report fairly presents, in all material respects, the financial condition and
result of operations of the Company.  /s/Wilco
  GroenhuysenWilco GroenhuysenExecutive Vice
  President and Chief Financial OfficerFebruary 12,
  2010
<PAGE>

                                                                   Exhibit 23.1

                        Consent of Independent Auditors

   We consent to the incorporation by reference in the Registration Statements
(Form S-3 No. 333-66047 and Form S-3 No. 333-52696) and in the related
Prospectuses, in the Registration Statement (Form S-8 No. 33-71346) pertaining
to the Amended and Restated 1991 Stock Option Plan, in the Registration
Statement (Form S-8 No. 33-71350) pertaining to the 1992 Stock Option Plan, in
the Registration Statement (Form S-8 No. 33-80213) pertaining to the 1994 Stock
Option Plan, in the Registration Statement (Form S-8 No. 33-80215) pertaining
to the 1995 Stock Option Plan, in the Registration Statement (Form S-8 No.
333-16349) pertaining to the 1996 Stock Option Plan, in the Registration
Statement (Form S-8 No. 333-28971) pertaining to the Houston Biotechnology
Incorporated Replacement Stock Option Plan, the Houston Biotechnology
Incorporated 1994A Stock Option Plan, and the Houston Biotechnology
Incorporated 1992 Subordinated Stock Option Plan, in the Registration Statement
(Form S-8 No. 333-86117) pertaining to the 1997 Stock Option Plan, and in the
Registration Statement (Form S-8 No. 333-86119) pertaining to the 1999 Stock
Option Plan, in the Registration Statement (Form S-8 No. 333-39084) pertaining
to the 2000 Stock Option Plan, in the Registration Statement (Form S-8 No.
333-55222) pertaining to the 2000 Non-Director/Officer Employee Stock Option
Plan, in the Registration Statement (Form S-8 No. 333-55224) pertaining to the
2001 Non-Director/Officer Employee Stock Option Plan, and, in the Statement
(Form S-8 No. 333-72154) pertaining to the 2001 Stock Option Plan of our report
dated February 19, 2002 with respect to the consolidated financial statements
of Medarex, Inc. included in this Annual Report (Form 10-K) for the year
ended December 31, 2001.

                                      /S/  ERNST & YOUNG LLP

MetroPark, New Jersey
March 26, 2002
EXHIBIT 23



INDEPENDENT AUDITORS' CONSENT AND REPORT ON SCHEDULE

We consent to the incorporation by reference in Registration Statements No.
33-41050, No. 33-26271, No. 33-12276, No. 33-48808, No. 33-65132, No. 33-
60891 and 33-13013 of Optical Coating Laboratory, Inc. on Form S-8 and
Registration Statements No. 33-61177 and No. 33-65319 on Form S-3 of
Optical Coating Laboratory, Inc. of our report dated December 19, 1997,
appearing in this Annual Report on Form 10-K/A of Optical Coating Laboratory,
Inc. for the year ended October 31, 1997.

Our audits of the consolidated financial statements referred to in our
aforementioned report also included the financial statement schedule of
Optical Coating Laboratory, Inc., listed in Item 14(a)(2).  The financial
statement schedule is the responsibility of the Company's management.  Our
responsibility is to express an opinion based on our audits.  In our
opinion, based on our audits and the report by other auditors referred to
in our aforementioned report, the financial statement schedule, when
considered in relation to the basic financial statements taken as a whole,
presents fairly, in all material respects, the information set forth
therein.


DELOITTE & TOUCHE LLP


San Jose, California
February 19, 1998
<PAGE>


                                                                    EXHIBIT 32.2


                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

         Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and in
connection with the Quarterly Report on Form 10-Q of Post Properties, Inc.
("Post") and Post Apartment Homes, L.P. ("PAH", and together with Post, the
"Registrants") for the quarter ended March 31, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, the President and Chief Executive Officer of Post and Post GP
Holdings, Inc., PAH's general partner, certifies that:

         1)       the Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         2)       the information contained in the Report fairly presents, in
                  all material respects, the financial condition and results of
                  operations of the Registrants.



/s/ Christopher J. Papa
------------------------------
Christopher J. Papa
Executive Vice President and
Chief Financial Officer
May 10, 2004


                                      -54-
To: "John V. Massingale" <john@grcci.com>, 

Cc:

Bcc:

Subject: Re: Request for Modification of Test Schedule - Ethanedioic acid [CAS RN 144-62-7]

From: Paul Campanella/DC/USEPA/US - Wednesday 10/31/2012 03:22 PM

John, After carefully considering your request for an extension of the time needed to complete testing and 

submit final reports to the EPA we are willing to grant this extension. Our decision is based on our 

extensive discussions with you and your cooperation in working with us to resolve the numerous issues 

that have surfaced as we worked through the nomenclature and approval of protocols. 

Paul J. Campanella, Ph.D.

Chemical Information and Testing Branch

Chemical Control Division

U.S. Environmental Protection Agency

Washington, D.C. 

202-564-8091

"John V. Massingale" ***This E-mail Contains No CBI*** 10/29/2012 04:54:30 PM

From: "John V. Massingale" <john@grcci.com>

To: Paul Campanella/DC/USEPA/US@EPA

Date: 10/29/2012 04:54 PM

Subject: Request for Modification of Test Schedule - Ethanedioic acid [CAS RN 144-62-7]

***This E-mail Contains No CBI***

Dear Paul,

As we discussed last week, I include here a copy of the letter that is being sent overnight to EPA on 

behalf of the Oxalic Acid Testing Consortium comprised of Univar USA, Inc. and WEGO Chemical and 

Mineral Corporation. This letter requests a modification of test schedule for testing conducted by the 

Consortium under the TSCA Section 4 Test Rule (Second Group of HPV chemicals) for: 

Ethanedioic acid 

(Oxalic acid )

CAS RN 144-62-7]

Specifically, the letter requests a three-month extension due to nomenclature, study plan, and minor 

technical issues that have arisen in the course of this work. 

We greatly appreciate the Agency's consideration in this matter. If there are any questions or comments, 

please do not hesitate to contact me. 

Thank you,

John

_______________________________

John V. Massingale

Greenwich Chemical Consulting, Inc.

3300 PGA Boulevard, Suite 635

Palm Beach Gardens, FL 33410
T 561.578.8110

F 561.578.8120

E john@grcci.com

www.grcci.com

EPA-Letter-October 2012-Final.pdf
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 02-1802

FREHIWOT AYELE, Petitioner, versus U.S. IMMIGRATION & NATURALIZATION SERVICE; JOHN ASHCROFT, Attorney General, Respondents.

On Petition for Review of an Order of the Board of Immigration Appeals. (A75-363-823) Submitted: March 18, 2003 Decided: March 26, 2003 Before WILKINSON and WILLIAMS, Circuit Judges, and HAMILTON, Senior Circuit Judge. Petition denied by unpublished per curiam opinion. Manuel Rivera, Jr., Arlington, Virginia, for Petitioner. Robert D. McCallum, Jr., Assistant Attorney General, Ernesto H. Molina, Jr., Senior Litigation Counsel, Russell J.E. Verby, Office of Immigration Litigation, UNITED STATES DEPARTMENT OF JUSTICE, Washington, D.C., for Respondents. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Frehiwot Ayele, a native and citizen of Ethiopia, seeks review of the Board of Immigration Appeals’ (“Board”) decision and order affirming, without opinion, her appeal from the immigration judge’s order finding her removable and denying her applications for asylum and withholding of removal. On appeal, Ayele claims that the Board erred in affirming the decision of the immigration judge without opinion, after review by a single Board member, in accordance with the procedure set out in 8 C.F.R. § 3.1(a)(7) (2002). We have reviewed the administrative record and the formal briefs on appeal and find Ayele’s challenges to the Board’s use of the streamlined review procedure to be without merit. See Albathani v. INS , 318 F.3d 365, 375-79 (1st Cir. 2003). We further find that summary affirmance was appropriate in this case under the factors set forth in § 3.1(a)(7)(ii). Accordingly, we deny Ayele’s petition for review. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

PETITION DENIED
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED February 14, 2007 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 05-20660 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus JONATHAN ELLIOT JACKSON, Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Southern District of Texas USDC No. 4:02-CR-120-6

-------------------- Before BARKSDALE, GARZA, and CLEMENT, Circuit Judges.
PER CURIAM: * Counsel appointed to represent Jonathan Elliot Jackson has requested leave to withdraw and has filed a brief as required by Anders v. California , 386 U.S. 738 (1967). Jackson has filed a response and moves for the appointment of new counsel. Our independent review of the record, counsel’s brief, and Jackson’s response discloses no nonfrivolous issue for appeal. Counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities, and the APPEAL IS DISMISSED. See 5 TH C IR . R. 42.2. The motion for appointment of new counsel is
DENIED.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1186 Introduced in House (IH)]

111th CONGRESS
  1st Session
                                H. R. 1186

To prohibit the use of funds to transfer individuals detained at Naval 
 Station, Guantanamo Bay, Cuba, to facilities in Virginia or to house 
                  such individuals at such facilities.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 25, 2009

   Mr. Forbes (for himself, Mr. Cantor, and Mr. Wolf) introduced the 
 following bill; which was referred to the Committee on Armed Services

_______________________________________________________________________

                                 A BILL

 
To prohibit the use of funds to transfer individuals detained at Naval 
 Station, Guantanamo Bay, Cuba, to facilities in Virginia or to house 
                  such individuals at such facilities.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PROHIBITION ON USE OF FUNDS TO TRANSFER INDIVIDUALS DETAINED 
              AT NAVAL STATION, GUANTANAMO BAY, CUBA, TO FACILITIES IN 
              VIRGINIA.

    None of the funds appropriated or otherwise made available to any 
Federal department or agency may be used to transfer any individual 
detained by the United States at Naval Station, Guantanamo Bay, Cuba, 
to any military installation located in the Commonwealth of Virginia or 
any Federal detention center located in the Commonwealth of Virginia or 
to house any such individual at such an installation or detention 
center.
                                 <all>
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1996
<PERIOD-START>                             APR-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                           3,482
<SECURITIES>                                     4,547
<RECEIVABLES>                                   19,565
<ALLOWANCES>                                         0
<INVENTORY>                                      6,021
<CURRENT-ASSETS>                                34,191
<PP&E>                                           4,217
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  42,343
<CURRENT-LIABILITIES>                            8,033
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             3
<OTHER-SE>                                      33,146
<TOTAL-LIABILITY-AND-EQUITY>                    42,343
<SALES>                                         43,789
<TOTAL-REVENUES>                                43,789
<CGS>                                           22,224
<TOTAL-COSTS>                                   22,224
<OTHER-EXPENSES>                                16,296
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  30
<INCOME-PRETAX>                                  5,239
<INCOME-TAX>                                     1,894
<INCOME-CONTINUING>                              3,345
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,345
<EPS-PRIMARY>                                      .36
<EPS-DILUTED>                                        0
        

</TABLE>